Findings reveal structural features influencing mu-opioid receptor antagonism and respiratory effects in phenylfentanyl analogues, implying safer design.
did not induce respiratory depression at the tested dose, indicating a lack of intrinsic respiratory liability. These findings delineate structural features governing MOR antagonism and respiratory effects within a fentanyl-derived scaffold.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: